Ocular Therapeutix, Inc. (OCUL)
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cataract surgery; and DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is also developing OTX-TKI, an axitinib intravitreal implant that is in phase 1 clinical trials for the treatment of wet age-related macular degeneration and other retinal diseases; OTX-TIC, a travoprost intracameral implant, which is in phase 2 clinical trials for the treatment of open-angle glaucoma or ocular hypertension; OTX-CSI, a cyclosporine intracanalicular insert that has completed phase 2 clinical trials for the treatment of dry eye disease; and OTX-DED, a dexamethasone intracanalicular insert, which is in phase 2 clinical trials for the short-term treatment of the signs and symptoms of dry eye disease. The company has a strategic collaboration with Regeneron Pharmaceuticals, Inc. (Regeneron) for the development and commercialization of products using the Company's sustained-release hydrogel in combination with Regeneron's large molecule VEGF-targeting compounds for the treatment of retinal diseases; and AffaMed Therapeutics Limited for the development and commercialization of DEXTENZA and OTX-TIC, as well as a discovery collaboration with Mosaic Biosciences to identify new targets and therapeutic agents for the treatment of dry age-related macular degeneration (dMAD). Ocular Therapeutix, Inc. was incorporated in 2006 and is headquartered in Bedford, Massachusetts.
$1.40B
Mr. Antony Mattessich
228.00
Bedford, MA
Jul 25, 2014
-8.24
$-1.09
15.34
16.64
-227.16%
-10.83
-0.30
3.97
23.14
16.55
-26.76%
-62.56%
Similar stocks (11)
Day One Biopharmaceuticals, Inc.
DAWN
Terns Pharmaceuticals, Inc.
TERN
Inozyme Pharma, Inc.
INZY
Amylyx Pharmaceuticals, Inc.
AMLX
HOOKIPA Pharma Inc.
HOOK
Acumen Pharmaceuticals, Inc.
ABOS
Assembly Biosciences, Inc.
ASMB
X4 Pharmaceuticals, Inc.
XFOR
PDS Biotechnology Corporation
PDSB
CytomX Therapeutics, Inc.
CTMX
Spero Therapeutics, Inc.
SPRO
ETF Exposure (28)
Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF
PILL
2.1603904289%
iShares Micro-Cap ETF
IWC
0.3515%
Invesco Nasdaq Biotechnology ETF
IBBQ
0.131%
iShares Russell 2000 Growth ETF
IWO
0.10358%
Vanguard Russell 2000 Growth Index Fund
VTWG
0.1%
Vanguard U.S. Momentum Factor ETF
VFMO
0.07%
iShares Russell 2000 ETF
IWM
0.05142%
Vanguard Russell 2000 Index Fund
VTWO
0.05%
ProShares Ultra Nasdaq Biotechnology
BIB
0.03771457457525115%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0.02%
Vanguard Extended Market Index Fund
VXF
0.02%
ProShares Ultra Russell2000
UWM
0.019454244274121374%
Fidelity MSCI Health Care Index ETF
FHLC
0.01378587%
Vanguard Health Care Index Fund
VHT
0.01%
ProShares UltraPro Russell2000
URTY
0.00958802645044285%
ProShares Hedge Replication ETF
HDG
0.008151318480323898%
iShares Core S&P Total U.S. Stock Market ETF
ITOT
0.0028%
iShares Russell 3000 ETF
IWV
0.00265%
Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
GSSC
0%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Similar stocks (11)
Day One Biopharmaceuticals, Inc.
DAWN
Terns Pharmaceuticals, Inc.
TERN
Inozyme Pharma, Inc.
INZY
Amylyx Pharmaceuticals, Inc.
AMLX
HOOKIPA Pharma Inc.
HOOK
Acumen Pharmaceuticals, Inc.
ABOS
Assembly Biosciences, Inc.
ASMB
X4 Pharmaceuticals, Inc.
XFOR
PDS Biotechnology Corporation
PDSB
CytomX Therapeutics, Inc.
CTMX
Spero Therapeutics, Inc.
SPRO
ETF Exposure (28)
Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF
PILL
2.1603904289%
iShares Micro-Cap ETF
IWC
0.3515%
Invesco Nasdaq Biotechnology ETF
IBBQ
0.131%
iShares Russell 2000 Growth ETF
IWO
0.10358%
Vanguard Russell 2000 Growth Index Fund
VTWG
0.1%
Vanguard U.S. Momentum Factor ETF
VFMO
0.07%
iShares Russell 2000 ETF
IWM
0.05142%
Vanguard Russell 2000 Index Fund
VTWO
0.05%
ProShares Ultra Nasdaq Biotechnology
BIB
0.03771457457525115%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0.02%
Vanguard Extended Market Index Fund
VXF
0.02%
ProShares Ultra Russell2000
UWM
0.019454244274121374%
Fidelity MSCI Health Care Index ETF
FHLC
0.01378587%
Vanguard Health Care Index Fund
VHT
0.01%
ProShares UltraPro Russell2000
URTY
0.00958802645044285%
ProShares Hedge Replication ETF
HDG
0.008151318480323898%
iShares Core S&P Total U.S. Stock Market ETF
ITOT
0.0028%
iShares Russell 3000 ETF
IWV
0.00265%
Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
GSSC
0%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%